Activated effector CD8+ T cells that recognize tumor antigens can attack and eradicate tumor cells through perforin and granzyme B-mediated cytolysis, Fas/FasL pathway activation, and/or cytokine release (such as IFN-γ and TNF-α) (Figure 3). This evidence concerns the gene CD8A and neoplasm.